FUJIFILM WAKO AUTOMATION TO PROVIDE COMPLIMENTARY IMAGE ANALYSIS SUPPORT TO ACCELERATE COVID-19 FINDINGS
FUJIFILM Wako Automation Corporation, announced today that it will provide free image analysis services to help scientists and researchers rapidly and accurately analyze imaging data that may lead to the next breakthrough on COVID-19. The custom analysis service, as well as additional webinar training offerings, will allow scientists to leverage the full potential of leading open-source platforms including for CellProfiler™, ImageJ, KNIME®, QuPath, Ilastik, and other custom Python scripts.
Scientists and researchers are working around-the-clock to contain and find treatment options to address COVID-19. As a result of the pandemic, conducting research proves to be a challenge, according to a poll of BioSpace readers, where 84% of respondents said that COVID-19 was affecting their work. The image analysis support offered by FUJIFILM Wako Automation will enable scientists and researchers to continue to evolve lab research and advance experiments.
The first seminar is scheduled for: June 11 at 10AM EST. Please register here: https://www.wakoautomation.com/events
FUJIFILM Wako Automation Corporation has been in business since 2010 and is a subsidiary of FUJIFILM Wako Pure Chemical Corporation of Japan. Wako designs custom automated laboratory systems. We are known for robust industrial designs customized to your vision. Wako also distributes Yokogawa’s CV8000 confocal high content screening system.
FUJIFILM Corporation, Tokyo, Japan is one of the major operating companies of FUJIFILM Holdings Corporation. The company brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2019, the company had global revenues of $22 billion, at an exchange rate of 111 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
All product and company names herein may be trademarks of their registered owners.
 Dutton, G., (March 17, 2020). BioSpace.com. “COVID-19's Impact on Life Sciences Researchers.” Retrieved from https://www.biospace.com/article/covid-19-s-impact-on-life-sciences-research/